Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
10/15/1998 | CA2286452A1 Pyrimido-isoquinoline compounds with anticonvulsive action |
10/15/1998 | CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome |
10/15/1998 | CA2286204A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators |
10/15/1998 | CA2286008A1 Anti-peptide antibody against human cytochrome p450 3a4 |
10/15/1998 | CA2285933A1 Assay for ligands to tyrosine kinase receptors |
10/15/1998 | CA2285906A1 Hydroxamic acid derivatives |
10/15/1998 | CA2285604A1 Somatostatin agonists |
10/15/1998 | CA2285556A1 Calcilytic compounds |
10/15/1998 | CA2285454A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
10/15/1998 | CA2285388A1 Compounds |
10/15/1998 | CA2285223A1 Somatostatin agonists |
10/15/1998 | CA2285192A1 Pharmacological agents |
10/15/1998 | CA2284996A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
10/15/1998 | CA2281843A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove |
10/15/1998 | CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor |
10/14/1998 | EP0870831A1 Histidine kinase polypeptides |
10/14/1998 | EP0870827A2 Tumor necrosis factor related receptor, TR6 |
10/14/1998 | EP0870768A1 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
10/14/1998 | EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
10/14/1998 | EP0870759A1 Aminated 6,7,8,9-tetrahydro-cyclopenta[a]naphtalene- and 2,3-dihydro-cyclopenta[e]indene-derivatives, process for their preparation and pharmaceutical compsitions containing them |
10/14/1998 | EP0870504A2 New compositions comprising biologically active silicon |
10/14/1998 | EP0870198A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
10/14/1998 | EP0870049A2 Complementary adenoviral vector systems and cell lines |
10/14/1998 | EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin |
10/14/1998 | EP0870035A2 A novel protein kinase required for ras signal transduction |
10/14/1998 | EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2 |
10/14/1998 | EP0870027A1 Novel c-mpl receptor agonists |
10/14/1998 | EP0870023A1 Osteoprotegerin |
10/14/1998 | EP0870019A2 Cell activation process and reagents therefor |
10/14/1998 | EP0869972A1 Chemokine from niddm pancreas |
10/14/1998 | EP0869970A1 Endothelial cell proliferation inhibitor and method of use |
10/14/1998 | EP0869968A1 Growth-hormone secretagogues |
10/14/1998 | EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
10/14/1998 | EP0869966A1 Prodrugs of thrombin inhibitors |
10/14/1998 | EP0869958A1 Novel indole-2,3-dione-3-oxime derivatives |
10/14/1998 | EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
10/14/1998 | EP0869954A1 Novel heterocyclic compounds |
10/14/1998 | EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
10/14/1998 | EP0869946A1 Phenylimidazolidines and use thereof as an antiandrogenic agent |
10/14/1998 | EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents |
10/14/1998 | EP0869944A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS |
10/14/1998 | EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
10/14/1998 | EP0869816A1 Dry compositions |
10/14/1998 | EP0869809A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
10/14/1998 | EP0869806A1 A pharmaceutical composition comprising plant worms and muirapuama |
10/14/1998 | EP0869804A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
10/14/1998 | EP0869799A1 Method and material for hair therapy |
10/14/1998 | EP0869794A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
10/14/1998 | EP0869793A1 Hemoregulatory compounds |
10/14/1998 | EP0869791A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
10/14/1998 | EP0869787A1 Vitronectin receptor antagonists |
10/14/1998 | EP0869778A1 Improved perfluorocarbons for biological gas exchange and method |
10/14/1998 | EP0752982B1 Biphenyl derivatives as 5ht1d antagonists |
10/14/1998 | EP0741743B1 Cyclic neurokinin a antagonists |
10/14/1998 | EP0678090B1 Piperazine derivatives |
10/14/1998 | EP0673388B1 Double chain peptide compounds having hemoregulatory activity |
10/14/1998 | EP0673366B1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
10/14/1998 | EP0630248B1 Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis |
10/14/1998 | EP0577847B1 Morphinan derivative and medicinal use |
10/14/1998 | EP0543861B1 Imidazopyridine derivatives, process for their preparation and their application |
10/14/1998 | CN1196087A Novel protein HMW human MP52 |
10/14/1998 | CN1196057A Substituted phosphinic compounds and their use as pharmaceuticals |
10/14/1998 | CN1196053A Novel heterocyclic compounds for treatment of pain and use thereof |
10/14/1998 | CN1196049A Acylated derivatives of melatonin and its analogues, useful as medicaments |
10/14/1998 | CN1195985A Benzimidazole compounds |
10/14/1998 | CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells |
10/14/1998 | CN1195664A New benzoxazinedione derivatives, method of producing them and use thereof |
10/14/1998 | CN1195523A 组合物 The composition |
10/14/1998 | CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions |
10/14/1998 | CN1040211C Matrix metalloprotease inhibitors |
10/14/1998 | CA2235057A1 A cosmetic and pharmaceutical formulation containing an andiroba extract |
10/13/1998 | US5821371 Heterocyclic compounds and their preparation and use |
10/13/1998 | US5821370 Muscarinic cholinergic drugs |
10/13/1998 | US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity |
10/13/1998 | US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles |
10/13/1998 | US5821354 Synthesizing a dna sequence in at least two parts; labeling the 5' end of one with a radioisotope; hybridizing; ligating; useful to prevent uncontrolled cellular proliferation |
10/13/1998 | US5821331 Inhibit the proteolytic activity of proteases |
10/13/1998 | US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock |
10/13/1998 | US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion |
10/13/1998 | US5821256 Endothelin receptor antagonists |
10/13/1998 | US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
10/13/1998 | US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use |
10/13/1998 | US5821250 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
10/13/1998 | US5821240 Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof |
10/13/1998 | US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene |
10/13/1998 | US5821230 GnRH antagonist decapeptides |
10/13/1998 | US5821227 Modulators of cytokines of the tgf β superfamily |
10/13/1998 | US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide |
10/13/1998 | US5821124 Hybridoma cell lines and antibodies that bind noggin |
10/13/1998 | US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof |
10/13/1998 | US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte |
10/13/1998 | US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus |
10/13/1998 | US5820858 Methods and compositions for inhibiting CD14 mediated cell activation |
10/13/1998 | US5820849 Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes |
10/13/1998 | CA2132578C Method of tumor treatment |
10/13/1998 | CA1340082C Bovine interleukin-10c |
10/10/1998 | CA2233524A1 Novel compounds |
10/08/1998 | WO1998044128A1 Novel human serine carboxypeptidase |
10/08/1998 | WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
10/08/1998 | WO1998044105A1 Polypeptide expressed in the horny layer of epidermis and use thereof |